71610 0442 30
Gabapentin
Product Images NDC 71610-442
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Image 01)
The text appears to be a chart or graph containing information on mean pain score and the use of a medication called 'Parkod' and another medication called 'Gabapentin' for pain relief. It also mentions 'Baseline 1' and a time period of weeks. However, without more context or explanation, it is difficult to provide a full description.*
Figure 2 (Image 02)
This is a graph showing the mean pain scores over a 7-week fixed dose period for a placebo and two different doses of gabapentin (1800 mg/day and 2400 mg/day). The x-axis displays the weeks while the y-axis shows the mean pain score.*
Figure 3 (Image 03)
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
